Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A lysine residue is an amino acid side chain present in proteins, distinguished by its ε-amino group. Lysine residues are essential for protein structure, stability, and function. They are the primary sites for diverse and biologically crucial post-translational modifications, such as acetylation, methylation, ubiquitination, and sumoylation, especially in the histone tails that regulate chromatin structure and gene expression. Lysines also frequently appear in enzyme active sites and play structural roles in binding and catalysis. Because they are ubiquitous and numerous in proteins, targeting specifically a lysine residue (as opposed to a distinct protein or receptor) is not usually considered a therapeutic strategy, although certain drugs are designed to covalently react with lysines at functional sites on specific proteins[1][6].
Covalent modification of lysine preventing functional protein interactions. Inhibition or enhancement of lysine post-translational modifications (e.g., acetylation, methylation) for epigenetic drugs.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine residue (K).